International Journal of Drug Delivery Technology
Volume 14, Issue 4

Formulation Challenges in Dermal Drug Delivery Systems: A Comprehensive Review of Physicochemical Properties and Advanced Delivery Strategies

Vijaykumar V1*, Saikiran M1, Bharathy V R1, Ubaidulla U2

1School of Pharmacy, Sathyabama Institute of Science and Technology, Jeppiaar Nagar, Rajiv Gandhi Salai, Chennai- 600119, Tamil Nadu, India.

2Crescent School of Pharmacy, B. S. Abdur Rahman Crescent Institute of Science and technology, GST Road, Vandalur, Chennai-600048, Tamil Nadu, India. 

Received: 23rd Sep 2024; Revised: 29th Oct, 2024; Accepted: 15th Nov, 2024; Available Online: 25th Dec, 2024

ABSTRACT

Dermal drug delivery systems (DDS) offer a promising route for localized and systemic therapy, bypassing gastrointestinal degradation and first-pass metabolism. However, formulating effective DDS poses significant challenges due to the complex barrier function of the skin, particularly the stratum corneum, and the critical influence of a drug’s physicochemical properties. This review provides a comprehensive analysis of formulation challenges in dermal drug delivery, focusing on several key physicochemical properties such as lipophilicity, molecular weight, solubility, pKa, and chemical stability that dictate drug absorption, bioavailability, and therapeutic efficacy. By synthesizing data from over 200 research papers published in the last five years, this review identifies key trends, innovations, and persistent challenges in optimizing DDS. Lipophilicity and molecular weight were found to significantly impact skin permeability, with moderately lipophilic drugs (logP 2-4) and molecules below 500 Da showing optimal absorption profiles. Poorly soluble drugs exhibited low bioavailability unless advanced formulation strategies like nanoemulsions, solid lipid nanoparticles (SLNs), and microneedles were employed to enhance solubility and penetration. Similarly, drugs with pKa values close to the skin’s pH demonstrated superior permeability, emphasizing the importance of pH-optimized formulations. Stability concerns, particularly for drugs prone to oxidation or crystallization, were effectively mitigated using lipid-based carriers and amorphous solid dispersions, which improved both solubility and shelf life. The review highlights the role of viscosity, surface tension, and thermal properties in determining drug release and penetration in various DDS formulations. Nanotechnological advancements, such as the use of nanostructured lipid carriers (NLCs) and microneedles, offer promising solutions for delivering larger or more challenging molecules, including peptides and proteins. Finally, the use of magnetically responsive nanoparticles presents new opportunities for controlled drug release but requires further research to address stability and reactivity concerns. This review concludes by outlining the current gaps in the understanding of the physicochemical factors influencing DDS and suggests future research directions aimed at improving drug permeability, stability, and bioavailability. Addressing these challenges through advanced formulation techniques will be critical for enhancing the clinical efficacy of dermal drug delivery systems.

Keywords: Dermal drug delivery, Physicochemical properties, Skin permeability, Nanoemulsions, Transdermal systems, Controlled release & magnetically responsive nanoparticles.

How to cite this article: Vijaykumar V, Saikiran M, Bharathy V R, Ubaidulla U. Formulation Challenges in Dermal Drug Delivery Systems: A Comprehensive Review of Physicochemical Properties and Advanced Delivery Strategies International Journal of Drug Delivery Technology. 2024;14(4):2154-2165 . doi: 10.25258/ijddt.14.4.29

REFERENCES

  1. Phatale V, Vaiphei KK, Jha S, Patil D, Agrawal M, Alexander A. Overcoming skin barriers through advanced transdermal drug delivery approaches. J Control Release. 2022;351:361-80. doi: 10.1016/j.jconrel.2022.09.025, PMID 36169040.
  2. Tapfumaneyi P, Imran M, Alavi SE, Mohammed YH. Science of, and insights into, thermodynamic principles for dermal formulations. Drug Discov Today. 2023;28(4):103521. doi: 1016/j.drudis.2023.103521,PMID 36754143.
  3. Ruiz VH, Encinas-Basurto D, Sun B, Eedara BB, Dickinson SE, Wondrak GT et al. Design, physicochemical characterization, and in vitro permeation of innovative resatorvid topical formulations for  targeted  skin  drug Pharmaceutics. 2022;14(4). doi:10.3390/pharmaceutics14040700, PMID 35456534.
  4. Ochalek Barrier properties of stratum corneum lipid model membranes based on ceramide [AP] and. EOS; 2012. doi: 10.25673/750.
  5. Kadyrov J, Ruiz-Perez L, Benson HA, Mancera RL. Characterisation of the molecular mechanism of permeation of the prodrug Me-5ALA across the human stratum corneum using Molecular Dynamics simulations. Int J Mol Sci. 2022;23(24). doi: 10.3390/ijms232416001, PMID 36555643.
  6. Li, G. F., Fumio, K., & Liu, L. J. (2002). Influence of different layers of skin on the percutaneous absorption of drugs with different lipophilicity. JOURNAL- MEDICAL COLLEGES OF PLA-ENGLISH EDITION-, 17(2), 152-156.7.
  7. Mueller, , Trapp, M., & Neubert, R. H. H. (2019). The effect of hydrophilic penetration/diffusion enhancer on stratum corneum  lipid  models:  Part  II*: DMSO. Chemistry and physics of lipids, 225, 104816.
  8. Hawthorne DR, Pannala AS, Sandeman S, Lloyd AW. Sustained and targeted delivery of hydrophilic drug compounds: a review of existing and novel technologies from bench to bedside. J Drug Deliv Sci Technol. 2022;78. doi: 10.1016/j.jddst.2022.103936.
  9. Chen CP, Chen CC, Huang CW, Chang Evaluating molecular properties involved in transport of small molecules in stratum corneum: A quantitative structure- activity relationship for skin permeability. Molecules. 2018;23(4). doi: 10.3390/MOLECULES23040911,PMID 29662033.
  10. Cláudia Paiva-Santos, A., Gama, M., Peixoto, D., Sousa-Oliveira, I., Ferreira-Faria, I., Zeinali, M., Abbaspour-Ravasjani, S., Mascarenhas-Melo, F., Hamishehkar, H., & Veiga, F. (2022). Nanocarrier- based dermopharmaceutical formulations for the topical management of atopic International Journal of Pharmaceutics, 618(121656), 121656.https://doi.org/10.1016/j.ijpharm.2022.121656
  11. Qu F, Geng R, Liu Y, Zhu Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment. Theranostics. 2022;12(7):3372-406. doi: 10.7150/thno.69999, PMID35547773.
  12. Vinod Pote, S., Bavaskar, K., & Jain, A. (2022). Solubility Enhancement of Poorly Soluble Drug by using different Techniques. Research Journal of Pharmaceutical Dosage Forms and Technology, 315–https://doi.org/10.52711/0975-4377.2022.00052
  13. Reddy, K. R., Reddy, V. J., & Palagati, S. (2022). An overview of lipid nanoparticles for drug In Issues and Developments in Medicine and Medical Research Vol. 7 (pp. 1–8). Book Publisher International (a part of SCIENCE DOMAIN International).
  14. Akombaetwa N, Ilangala AB, Thom L, Memvanga PB, Witika BA, Buya AB. Current advances in lipid nanosystems intended for topical and transdermal drug delivery applications. Pharmaceutics. 2023;15(2). doi: 10.3390/pharmaceutics15020656, PMID 36839978.
  15. Lukić M, Pantelić I, Savić SD. Towards optimal pH of the skin and topical formulations: from the current state of the art to tailored Cosmetics. 2021;8(3). doi: 10.3390/COSMETICS8030069.
  16. Veronica N, Heng PW, Liew CV. Ensuring product stability - choosing the right excipients. J Pharm Sci. 2022;111(8):2158-71. doi: 1016/j.xphs.2022.05.001,PMID 35526577.
  17. Baghel, P., Roy, A., Verma, S., Satapathy, T., & Bahadur, S. (2020). Amelioration of lipophilic compounds in regards to bioavailability as self- emulsifying drug delivery system (SEDDS). Future Journal of Pharmaceutical Sciences, 6(1). https://doi.org/10.1186/s43094-020-00042-0
  18. Gupta P, Patel DS. A Review on nano-emulsion based gel formulations: emulgel, technology and recent advances. PCI- Approved-IJPSN. 2022;15(1):5741-62. doi: 10.37285/ijpsn.2022.15.1.3.
  19. Shivhare S, Jain AP, Jain T, Vishwakarma R, Vishwakarma PK, Prajapati S et al. Formulation, development and characterization of transdermal patches of glipizide. Int J Med Sci Pharm Res. 2022;8(3):1-7. doi: 10.22270/ijmspr.v8i3.47.
  20. Aslam H, Shukrullah S, Naz MY, Fatima H, Hussain H, Ullah S et al. Current and future perspectives of multifunctional magnetic nanoparticles based controlled drug delivery systems. J Drug Deliv Sci Technol. 2022;67. doi: 10.1016/j.jddst.2021.102946.
  21. Iliopoulos F, Sil BC, Evans CL. The role of excipients in promoting topical and transdermal delivery: current limitations and future perspectives. Front Drug Deliv. 2022;2. doi: 10.3389/fddev.2022.1049848.
  22. Malan, S. F., D. J. Chetty, and J. Du Plessis. "Physicochemical properties of drugs and membrane permeability." South African journal of science 7 (2002): 385-391.
  23. Pitassi, L. H. U., & Jordão, J. M. (2021). How to Optimize Drug Delivery in Dermatology?. Drug Delivery in Dermatology: Fundamental and Practical Applications, 11-27.
  24. Chen X, Xiao H, Shi X, Zhao Q, Xu X, Fan P et al. Bibliometric analysis and visualization of transdermal drug delivery research in the last decade: global research trends and hotspots. Front Pharmacol. 2023;14:1173251. doi: 3389/fphar.2023.1173251,PMID 37397493.
  25. Yao S, Chen N, Sun X, Wang Q, Li M, Chen Y. Size- dependence of the skin penetration of andrographolide nanosuspensions: in vitro release-ex vivo permeation correlation and visualization of the delivery Int J Pharm. 2023;641:123065.              doi: 10.1016/j.ijpharm.2023.123065, PMID 37225025.
  26. Kilian D, Lemmer HJ, Gerber M, Du Preez JL, du Plessis J. Exploratory data analysis of the dependencies between skin permeability, molecular weight and log Pharmazie. 2016;71(6):311-9. doi:10.1691/PH.2015.5170, PMID 27455549.
  27. KUMAR A, M, R. Solubility enhancement techniques: A comprehensive World J Bio Pharm HealthSci. 2023;13(3):414-149.doi: 10.30574/wjbphs.2023.13.3.0125.
  28. Hemani G, Gkatzionis A, Tilling K, Davey Smith GD. Sensitivity analyses gain relevance by fixing parameters observable during the empirical analyses. Genet Epidemiol. 2023;47(6):461-2. doi: 1002/gepi.22530, PMID 37417943.
  29. Maier MR, VanderWeele TJ, Mathur MB. Using selection models to assess sensitivity to publication bias: A tutorial and call for more routine use. Campbell Syst Rev. 2022;18(3):e1256. doi: 10.1002/cl2.1256, PMID
  30. Sachse T, Mathes T, Dorando E, Heß S, Thürmann PA, Schmiedl S et al. A review found heterogeneous approaches and insufficient reporting in overviews on adverse J Clin Epidemiol. 2022;151:104-12. doi: 10.1016/j.jclinepi.2022.08.004, PMID 35987405.
  31. Emeritus HA, Egidi G, Kochen MM, Popert U. Limitations of the study. Dtsch Ärztebl Int. 2018;115(8):133. doi:10.3238/ARZTEBL.2018.0133A, PMID 29526188.
  32. Bruno CD, Harmatz JS, Duan SX, Zhang Q, Chow CR, Greenblatt DJ. Effect of lipophilicity on drug distribution and elimination: influence of obesity. Br J Clin Pharmacol. 2021;87(8):3197-205. doi: 10.1111/BCP.14735, PMID 33450083.
  33. Souto EB, Fangueiro JF, Fernandes AR, Cano A, Sánchez-López E, Garcia ML et al. Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery. Heliyon. 2022;8(2):e08938. doi: 10.1016/j.heliyon.2022.e08938, PMID 35198788.
  34. Mojumdar EH, Sparr The effect of pH and salt on the molecular structure and dynamics of the skin. ColloidsSurf B Biointerfaces. 2021;198:111476. doi: 10.1016/J.COLSURFB.2020.111476, PMID 33293195.
  35. Han GE, Priefer A systematic review of various pKa determination techniques. Int J Pharm. 2023;635:122783. doi: 10.1016/j.ijpharm.2023.122783,PMID 36858133.
  36. Ahmed, , Hassan, W., Murtaza, G., Bakht, S., & Iqbal,M. (2020). Methods and Protocols for Drug Stability Studies. Drug Stability and Chemical Kinetics, 43-55.
  37. Souto EB, Baldim I, Oliveira WP, Rao R, Yadav N, Gama FM et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opin Drug Deliv. 2020;17(3):357- doi:10.1080/17425247.2020.1727883, PMID 32064958.
  38. Thirugnanasambandham, , Aasaithambi, K., Nizam, I., & Kuppusamy, G. (2023). Stability of Polymeric Micelles and Their Regulatory Status. In Polymeric Micelles: Principles, Perspectives and Practices (pp. 277-294). Singapore: Springer Nature Singapore.
  39. Sher M, Zahoor M, Shah SW, Khan Is particle size reduction linked to drug efficacy: an overview into nano initiatives in pharmaceuticals. Z Phys Chem. 2023;237(7):845-77. doi: 10.1515/zpch-2023-0221.
  40. Van Duong TV, Ni Z, Taylor LS. Phase behavior and crystallization kinetics of a poorly water-soluble weakly basic drug as a function of supersaturation and media composition. Mol Pharm. 2022;19(4):1146-59. doi: 1021/acs.molpharmaceut.1c00927, PMID 35319221.
  41. Goh CF, Hadgraft J, Lane ME. Thermal analysis of mammalian stratum corneum using differential scanning calorimetry for advancing skin research and drug delivery. Int J Pharm. 2022;614:121447. doi: 10.1016/j.ijpharm.2021.121447, PMID 34998922.